This inventor holds 2 USPTO granted patents. Top assignees: Merck + Co., Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4,770 
1 out of 3,705 
Years Active: 2003-2006
Title: **Qin Mei: An Innovator in Biopharmaceuticals**
Introduction
Qin Mei, an accomplished inventor based in North Wales, PA, has made significant contributions to the field of biopharmaceuticals. With two patents to his name, his work revolves around innovative techniques in antibody development and genetic analysis that hold promise for advancements in medical diagnostics and therapeutics.
Latest Patents
Qin's most recent inventions showcase his expertise in antibody development and genetic research. His first patent addresses **Antibodies for Human Cytochrome P450 2D6**, featuring antibodies known as 'MAb50-4' and 'MAb184-10'. These antibodies and their corresponding polypeptides are designed to compete for binding with CYP2D6, an important human enzyme. Notably, MAb50-4 can be produced by ATCC No. PTA-3489, while MAb184-10 is produced by ATCC No. PTA-1999.
The second patent involves the **Identification of a Region of the Major Surface Glycoprotein (MSG) Gene of Human Pneumocystis Carinii**. This patent discloses techniques for detecting human MSG gene sequences through sensitive methods such as PCR amplification. It also identifies seven novel genes encoding human MSG, showing high conservation among sequences, and details a conserved region of approximately 100 amino acids that differs significantly from rat-derived MSG.
Career Highlights
Throughout his career, Qin Mei has worked with prominent organizations, including the Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services, and Merck & Company, Inc. His work in these institutions has contributed to groundbreaking advancements in healthcare and therapeutic solutions.
Collaborations
Qin Mei has collaborated with notable professionals in the field, including Joseph A. Kovacs and Shengning Huang. Their combined expertise has facilitated the development of innovative solutions that enhance the understanding of human proteins and their applications in medicine.
Conclusion
Qin Mei's innovations in the realm of antibodies and genetic analysis underscore his role as a key contributor to biopharmaceutical research. As he continues to advance his work, his inventions pave the way for new therapeutic approaches, showcasing the significant impact that dedicated inventors can make in the field of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile